Cargando…

Baseline bone health status in multi-ethnic South African postmenopausal breast cancer patients at initiation of aromatase inhibitor therapy: A descriptive study

INTRODUCTION: Osteoporosis (OP) risk factor assessment and bone mineral density (BMD) testing are frequently omitted at baseline in aromatase inhibitor (AI) studies, which may lead to misinterpretation of AI associated bone loss. The present study describes bone health of South African postmenopausa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baatjes, Karin J., Kotze, Maritha J., McCaul, Micheal, Conradie, Magda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445512/ https://www.ncbi.nlm.nih.gov/pubmed/30939140 http://dx.doi.org/10.1371/journal.pone.0214153

Ejemplares similares

South African pre-hospital guidelines: Report on progress and way forward
por: McCaul, Michael, et al.
Publicado: (2016)

A description of pharmacological analgesia administration by public sector advanced life support paramedics in the City of Cape Town
por: Matthews, Ryan, et al.
Publicado: (2017)

Acute Pain in the African Prehospital Setting: A Scoping Review
por: Lourens, Andrit, et al.
Publicado: (2019)

Eczema Cured by Vaccination
por: Anderson, McCaul
Publicado: (1884)

Strengthening prehospital clinical practice guideline development in South Africa: Reflections from guideline experts
por: McCaul, Michael, et al.
Publicado: (2021)

Prehospital providers’ perspectives for clinical practice guideline implementation and dissemination: Strengthening guideline uptake in South Africa
por: McCaul, Michael, et al.
Publicado: (2019)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Prevalence of Sarcopenia in Older South African Patients Following Surgery for Fragility Fractures of the Hip
por: Laubscher, Cornelius V., et al.
Publicado: (2020)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Nutritional deficiency in South African adults scheduled for bariatric surgery
por: Sadhai, Prabash, et al.
Publicado: (2023)

Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
por: Lomax, Anna J., et al.
Publicado: (2013)

Pre-hospital clinical practice guidelines – Where are we now?
por: McCaul, Michael, et al.
Publicado: (2016)

Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers.
por: Yates, R. A., et al.
Publicado: (1996)

Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors
por: Gibb, Fraser W, et al.
Publicado: (2019)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2013)

Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors
por: Hong, Dongsheng, et al.
Publicado: (2017)

Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
por: Chen, Han, et al.
Publicado: (2020)

Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
por: Oosthuizen, Jaco, et al.
Publicado: (2021)

Strengthening prehospital clinical practice guideline implementation in South Africa: a qualitative case study
por: McCaul, Michael, et al.
Publicado: (2020)

Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer’s disease
por: Kotze, Maritha J., et al.
Publicado: (2012)

Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis
por: Chen, Shanshan, et al.
Publicado: (2022)

Osseocutaneous radial forearm flap with beavertail modification; a case report of a novel, single, reconstructive free flap for the tongue, floor of mouth and mandible
por: Henry, Alastair, et al.
Publicado: (2016)

From the Editors
por: McCaul, Mary E., et al.
Publicado: (2020)

Alcoholism Treatment in the United States
por: McCaul, Mary E., et al.
Publicado: (1994)

Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
por: Goss, Paul E, et al.
Publicado: (2007)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
por: Gonnelli, Stefano, et al.
Publicado: (2008)

Ovarian mucinous adenocarcinoma with functioning stroma in postmenopausal women: aromatase and SF-1 expressions
por: Hattori, Yuka, et al.
Publicado: (2015)

Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Restorative dentistry and oral rehabilitation: United Kingdom National Multidisciplinary Guidelines
por: Butterworth, C, et al.
Publicado: (2016)

‘Nasal flossing’: A case report of nasopharyngeal stenosis due to severe erosive lichen planus and a novel therapeutic intervention
por: Henry, Alastair, et al.
Publicado: (2018)

Best practice guidelines for professional nurses to provide self-management support to adults with tuberculosis-human immunodeficiency virus coinfection: A scoping review
por: Tornu, Eric, et al.
Publicado: (2023)

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
por: Moorhouse, Michelle, et al.
Publicado: (2019)

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
por: Pfeiler, G, et al.
Publicado: (2013)

Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
por: Ligibel, Jennifer A, et al.
Publicado: (2005)

Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy
por: Derzko, C., et al.
Publicado: (2007)

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers
por: Schuster, Eugene F., et al.
Publicado: (2023)

The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women
por: Lin, Jennifer H., et al.
Publicado: (2012)

Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC
por: Young, Patricia A., et al.
Publicado: (2021)

Emergency clinician output in a district hospital emergency centre: a cross-sectional analysis
por: Hoffe, Mary Elizabeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hf4srvgnuj09p4306ijr1tgqa7